Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Cutaneous Systemic Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03831438
What this trial is testing

Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, Diffuse
Bristol-Myers Squibb 9
Testing effectiveness (Phase 2)Study completedNCT04440592
What this trial is testing

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Tanabe Pharma America, Inc. 76
Testing effectiveness (Phase 2)Study completedNCT02370784
What this trial is testing

Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma

Who this might be right for
Scleroderma
Robyn T. Domsic, MD, MPH 24
Not applicableLooking for participantsNCT07090226
What this trial is testing

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study

Who this might be right for
Systemic SclerodermaDiffuse Cutaneous Scleroderma
Boston University 65
Testing effectiveness (Phase 2)Study completedNCT02503644
What this trial is testing

Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, DiffuseDiffuse Cutaneous Systemic Sclerosis
Inventiva Pharma 145
Testing effectiveness (Phase 2)Study completedNCT00442611
What this trial is testing

Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)

Who this might be right for
Scleroderma, DiffuseScleroderma, Systemic
Stanford University 10
Not applicableLooking for participantsNCT06387654
What this trial is testing

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

Who this might be right for
Autoimmune Bullous DermatosisDysimmune Dermatological DiseasesAuto-inflammatory Dermatological Diseases+1 more
University Hospital, Toulouse 800
Large-scale testing (Phase 3)Looking for participantsNCT06936215
What this trial is testing

Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 24
Testing effectiveness (Phase 2)Study completedNCT00016458
What this trial is testing

Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT01651143
What this trial is testing

Proof of Biological Activity of SAR100842 in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Sanofi 32
Testing effectiveness (Phase 2)Looking for participantsNCT05149768
What this trial is testing

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Not applicableLooking for participantsNCT07256418
What this trial is testing

Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma

Who this might be right for
Scleroderma
Centre Hospitalier Universitaire Dijon 60
Testing effectiveness (Phase 2)Ended earlyNCT02465437
What this trial is testing

Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Corbus Pharmaceuticals Inc. 42
Early research (Phase 1)Active Not RecruitingNCT06152172
What this trial is testing

CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101

Who this might be right for
Idiopathic Inflammatory MyopathiesDiffuse Cutaneous Systemic SclerosisSLE Nephritis+1 more
David Porter 24
Testing effectiveness (Phase 2)Study completedNCT00043706
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis

Who this might be right for
Systemic SclerosisScleroderma
Genzyme, a Sanofi Company
Early research (Phase 1)Active Not RecruitingNCT06255028
What this trial is testing

CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisIdiopathic Inflammatory Myopathies+1 more
Century Therapeutics, Inc. 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT02682511
What this trial is testing

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

Who this might be right for
Scleroderma, DiffuseScleroderma, SystemicScleroderma, Limited+5 more
Cumberland Pharmaceuticals 34
Testing effectiveness (Phase 2)WithdrawnNCT05098145
What this trial is testing

A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Talaris Therapeutics Inc.
Testing effectiveness (Phase 2)Study completedNCT04647890
What this trial is testing

Effects of FT011 in Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicScleroderma, DiffuseSclerosis, Systemic
Certa Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT04137224
What this trial is testing

Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
CSL Behring 27
Next Page